XpresSpa Group announced a collaboration between its XpresCheck division and EL AL Israel Airlines on a new pilot program beginning this week to provide COVID-19 PCR tests for passengers departing JFK International Airport (JFK) and arriving at Ben-Gurion International Airport (TLV) in Israel.
A negative COVID-19 PCR test is currently required for passengers of all ages, including those vaccinated, upon landing in Israel. Located in JFK T4, XpresCheck will collect specimens for rapid molecular testing services to EL AL passengers upon landing in Ben-Gurion International Airport.
“We look forward to collaborating with EL AL Israel Airlines in our mutual efforts to provide flyers with more accessible testing options to meet destination entry requirements and improve variant tracking,” said Doug Satzman, XpresSpa CEO. “Once the pilot program proves successful, we look to expand the EL AL relationship to other US originating flights to Israel.”
